AtriCure Reports Second Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/30/2026
- Wall St set for strongest quarter in years as risk appetite holds despite US-Iran war
- Dollar pushes higher, yen sinks to 40-year low
- Citi says bearish flows are building in Nasdaq and S&P 500
- Patrick and LCI Industries to merge in all-stock deal
- Logitech dips as BofA downgrades stock on demand outlook concerns
- Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
- EchoStar Prepares Dish DBS Bankruptcy Filing as Soon as Tuesday - WSJ
- Strategy stock jumps 7% as firm shifts to active capital management
- New leader board: Citi refreshes AI compute semiconductor picks
- Honeywell completes aerospace spin-off, splits into 3 companies
AtriCure Inc. (ATRC) PT Raised to $26 at Needham & Company Following 2Q Beat
July 28, 2017 8:07 AM EDTNeedham & Company raised its price target on AtriCure Inc. (NASDAQ: ATRC) to $26.00 (from $25.00) while maintaining a Buy rating following the company's 2Q. Revenue was $45.2M vs. consensus of $44.2M, EBITDA was ($0.4M) vs. consensus of ($1.9M), and EPS was ($0.21) vs. consensus of ($0.26).
For... More
